TRIVENI - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 3.2
| Stock Code | TRIVENI | Market Cap | 9,024 Cr. | Current Price | 412 ₹ | High / Low | 468 ₹ |
| Stock P/E | 28.5 | Book Value | 141 ₹ | Dividend Yield | 0.61 % | ROCE | 9.01 % |
| ROE | 8.32 % | Face Value | 1.00 ₹ | DMA 50 | 387 ₹ | DMA 200 | 376 ₹ |
| Chg in FII Hold | 0.48 % | Chg in DII Hold | -0.30 % | PAT Qtr | 109 Cr. | PAT Prev Qtr | 31.9 Cr. |
| RSI | 61.1 | MACD | 9.73 | Volume | 7,90,706 | Avg Vol 1Wk | 4,32,934 |
| Low price | 318 ₹ | High price | 468 ₹ | PEG Ratio | -2.07 | Debt to equity | 0.17 |
| 52w Index | 62.9 % | Qtr Profit Var | 92.0 % | EPS | 13.7 ₹ | Industry PE | 14.0 |
📊 TRIVENI shows moderate fundamentals with ROE at 8.32% and ROCE at 9.01%, reflecting weak efficiency. EPS of 13.7 ₹ supports earnings visibility, and quarterly PAT surged (109 Cr. vs 31.9 Cr.), highlighting strong recovery momentum. Debt-to-equity ratio of 0.17 ensures financial stability, while dividend yield of 0.61% adds modest returns. However, valuation is stretched with P/E at 28.5 compared to industry average of 14.0, and PEG ratio (-2.07) indicates poor growth prospects relative to valuation. Technical indicators (RSI 61.1, MACD 9.73) show near-term strength, with price trading above both 50 DMA (387 ₹) and 200 DMA (376 ₹).
💡 Entry Price Zone: Ideal accumulation range is between 370 ₹ – 390 ₹ near DMA supports. Buying closer to 410 ₹ may expose investors to valuation risk.
📈 Long-Term Holding Guidance: TRIVENI is moderately attractive for medium-term investors (12–18 months). Long-term holding is only justified if ROE/ROCE improve and growth metrics strengthen. Partial exits can be considered near 450–460 ₹ if valuations stretch without earnings improvement.
Positive
- EPS (13.7 ₹) supports earnings visibility.
- Low debt-to-equity (0.17) ensures financial stability.
- Quarterly PAT improved significantly (109 Cr. vs 31.9 Cr.).
- Technical indicators show near-term strength (RSI 61.1, MACD 9.73).
- FII holdings increased (+0.48%), reflecting foreign investor interest.
Limitation
- Low ROE (8.32%) and ROCE (9.01%).
- Negative PEG ratio (-2.07) indicates poor growth prospects.
- P/E (28.5) above industry average (14.0).
- Dividend yield (0.61%) is modest.
- DII holdings decreased (-0.30%), showing reduced domestic confidence.
Company Negative News
- Valuations remain expensive relative to industry benchmarks.
- Domestic institutional investors reduced holdings.
Company Positive News
- Quarterly profit variation (+92.0%) highlights strong recovery momentum.
- Foreign investor confidence improved with FII inflows.
Industry
- Industry PE at 14.0, much lower than TRIVENI’s 28.5, highlighting premium valuation.
- Engineering and sugar sector remains cyclical, dependent on demand and policy support.
Conclusion
⚠️ TRIVENI is a moderately attractive candidate with improving profitability and low debt, but weak efficiency metrics and stretched valuations limit its long-term appeal. Best suited for medium-term investors who can accumulate near support levels and exit on rallies unless ROE and growth metrics improve significantly.
Would you like me to extend this into a sugar sector overlay HTML comparing TRIVENI with Balrampur Chini, Dalmia Bharat Sugar, and Dhampur to highlight relative efficiency and valuation positioning?